StockMacro
Menu

HCA Healthcare

$475.57 +21% in 6 monthsMarket cap $99.3B

HCA on XNYS, Health Care, HCA Healthcare, Inc., job postings

Measures activity, not value. Not investment advice.

Revenue rose 5.8% to $78.7B over the last year while the stock is flat.

Written by AI from the data on this page, 21 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.

Industry
Services-general medical & surgical hospitals, nec (Health Care)
Employees
320,000
Website
hcahealthcare.com
Listed
NYSE, US
Last results
27 Oct 2026
Next results
expected around 26 Jan 2027 (an estimate: a year ago it reported on 27 Jan 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $19.8B, net income $1.6B.
Quarter to 31 Dec 2021: revenue $15.1B, net income $1.8BQuarter to 31 Dec 2021: revenue $15.1B, net income $1.8BQuarter to 31 Mar 2022: revenue $14.9B, net income $1.3BQuarter to 31 Mar 2022: revenue $14.9B, net income $1.3BQuarter to 30 Jun 2022: revenue $14.8B, net income $1.2BQuarter to 30 Jun 2022: revenue $14.8B, net income $1.2BQuarter to 30 Sep 2022: revenue $15.0B, net income $1.1BQuarter to 30 Sep 2022: revenue $15.0B, net income $1.1BQuarter to 31 Dec 2022: revenue $15.5B, net income $2.1BQuarter to 31 Dec 2022: revenue $15.5B, net income $2.1BQuarter to 31 Mar 2023: revenue $15.6B, net income $1.4BQuarter to 31 Mar 2023: revenue $15.6B, net income $1.4BQuarter to 30 Jun 2023: revenue $15.9B, net income $1.2BQuarter to 30 Jun 2023: revenue $15.9B, net income $1.2BQuarter to 30 Sep 2023: revenue $16.2B, net income $1.1BQuarter to 30 Sep 2023: revenue $16.2B, net income $1.1BQuarter to 31 Dec 2023: revenue $17.3B, net income $1.6BQuarter to 31 Dec 2023: revenue $17.3B, net income $1.6BQuarter to 31 Mar 2024: revenue $17.3B, net income $1.6BQuarter to 31 Mar 2024: revenue $17.3B, net income $1.6BQuarter to 30 Jun 2024: revenue $17.5B, net income $1.5BQuarter to 30 Jun 2024: revenue $17.5B, net income $1.5BQuarter to 30 Sep 2024: revenue $17.5B, net income $1.3BQuarter to 30 Sep 2024: revenue $17.5B, net income $1.3BQuarter to 31 Dec 2024: revenue $18.3B, net income $1.4BQuarter to 31 Dec 2024: revenue $18.3B, net income $1.4BQuarter to 31 Mar 2025: revenue $18.3B, net income $1.6BQuarter to 31 Mar 2025: revenue $18.3B, net income $1.6BQuarter to 30 Jun 2025: revenue $18.6B, net income $1.7BQuarter to 30 Jun 2025: revenue $18.6B, net income $1.7BQuarter to 30 Sep 2025: revenue $19.2B, net income $1.6BQuarter to 30 Sep 2025: revenue $19.2B, net income $1.6BQuarter to 31 Dec 2025: revenue $19.5B, net income $1.9BQuarter to 31 Dec 2025: revenue $19.5B, net income $1.9BQuarter to 31 Mar 2026: revenue $19.1B, net income $1.6BQuarter to 31 Mar 2026: revenue $19.1B, net income $1.6BQuarter to 30 Jun 2026: revenue $20.2B, net income $1.7BQuarter to 30 Jun 2026: revenue $20.2B, net income $1.7BQuarter to 30 Sep 2026: revenue $19.8B, net income $1.6BQuarter to 30 Sep 2026: revenue $19.8B, net income $1.6B
31 Dec 2021RevenueNet incometallest bar $20.2B30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$19.8B$1.6B
30 Jun 2026$20.2B$1.7B
31 Mar 2026$19.1B$1.6B
31 Dec 2025$19.5B$1.9B
30 Sep 2025$19.2B$1.6B
30 Jun 2025$18.6B$1.7B
31 Mar 2025$18.3B$1.6B
31 Dec 2024$18.3B$1.4B
30 Sep 2024$17.5B$1.3B
30 Jun 2024$17.5B$1.5B
31 Mar 2024$17.3B$1.6B
31 Dec 2023$17.3B$1.6B
30 Sep 2023$16.2B$1.1B
30 Jun 2023$15.9B$1.2B
31 Mar 2023$15.6B$1.4B
31 Dec 2022$15.5B$2.1B
30 Sep 2022$15.0B$1.1B
30 Jun 2022$14.8B$1.2B
31 Mar 2022$14.9B$1.3B
31 Dec 2021$15.1B$1.8B
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $78.7B $74.4B
Revenue growthRevenue of the last 12 months compared with the 12 months before. +5.8% +4.0%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $6.8B $6.3B
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $30.14 $25.87
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 63.5%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – – -9.1%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 8.6% 8.5% 5.1%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. – -44.4%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $6.0B $8.1B
CashCash, cash equivalents and short-term investments on the latest balance sheet. $908.0M $997.0M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $50.5B $44.5B
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $49.6B $43.5B
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. – 0.06
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. –
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 14.7 7.1
P/SPrice to sales: market cap divided by revenue of the last 12 months. 1.3 0.75
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 1.9 1.1
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. – 2.2
Dividend yieldDividends per share declared in the latest fiscal year divided by the share price. 0.61% 1.6%

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
HCA HealthcareHCA (this company) $99.3B14.71.3+5.8%8.6%
Tenet Healthcare Corporation NewTHC $20.9B5.50.95+6.2%17.2%
Universal Health ServicesUHS $10.3B7.10.56+8.0%8.0%
Regeneron PharmaceuticalsREGN $95.2B19.85.6+19%28.5%
3MMMM $91.8B26.03.6+1.7%14.0%
StrykerSYK $118.0B32.64.5+7.9%13.8%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$18.3M

bought $0, sold $18.3M

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+2.1%

1,337 13F filers vs 1,310

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

58%

120.6M shares held by 13F filers (30 Sep 2026) of 208.9M outstanding (26 Oct 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

2.3%

4.8M shares sold short (30 Oct 2026) of 208.9M outstanding (26 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

3.3

4.8M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-2.1%

4.9M shares sold short in the report before, 4.8M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

54%

54% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 57%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+3.6%

$19.8B vs $19.2B (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

+5.4%

$1.4B vs $1.3B (quarter ended 30 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$5.7M

4 quarters, $

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

51

51 articles in the last 7 days; its usual week has 6.5 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

7.8×

51 articles in the last 7 days; its usual week has 6.5.

Unusual now sharp changes in the last 90 days, compared with its own past

  • Lobbying spend $1.7M, 3.1× a year earlier
  • Short interest 6.1M, 1.5× a year earlier

Price $475.57 on 20 Nov 2026, -0.1% over 12 months (12-month range $361.32 to $545.13)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders sold a net $47.5M in the last 12 months (the 12 months before: -$12.3M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 60 published in the last 12 months, +2900% on the 12 months before.
Revenue per quarter. Revenue $19.8B in the latest quarter, +3.6% on a year earlier.
Capital spending per quarter. Capital spending $1.4B in the latest quarter, +5.4% on a year earlier.
Institutional holders (13F filers). 1,337 13F filers reported holding it in the latest 13F quarter, +8.9% on a year earlier.
Federal obligations. Federal obligations: $0 published in the last 12 months.
Lobbying spend. Lobbying spend: $5.7M published in the last 12 months, +56% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
27 Oct 2026Sharp changeLobbying spend jump: lobbying spend jump, 1.7M vs usual 695K (2026-09-30); 3.1x the same period a year earlier
11 Oct 2026Lobbying filingnew lobbying registration (JEFFREY J. KIMBELL & ASSOCIATES, INC.)
1 Sep 2026Sharp changeShort interest spike: short interest spike, 6.1M vs usual 4.2M (2026-08-14); 1.5x the same period a year earlier
18 Aug 2026Sharp changeShort interest spike: short interest spike, 6.1M vs usual 4.1M (2026-07-31); 1.5x the same period a year earlier
18 Jun 20268-K and other filingsDirector or officer change
18 Jun 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
19 May 2026Sharp changeWikipedia attention spike: wikipedia attention spike, 6,340 vs usual 2,834.50 (2026-05-11..2026-05-17); 2.0x the same week a year earlier
25 Feb 20268-K and other filingsDirector or officer change
25 Feb 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
11 Jul 20258-K and other filingsDirector or officer change
7 Jul 2025Lobbying filinglobbying engagement terminated (HORIZON GOVERNMENT AFFAIRS)
29 Apr 20258-K and other filingsDirector or officer change
15 Apr 2025Sharp changeShort interest spike: short interest spike, 5.6M vs usual 3.0M (2025-03-31); 2.1x the same period a year earlier
18 Mar 2025Sharp changeShort interest spike: short interest spike, 5.9M vs usual 2.9M (2025-02-28); 2.2x the same period a year earlier
11 Mar 2025Lobbying filingnew lobbying registration (RUBIN, TURNBULL & ASSOCIATES)
4 Mar 2025Sharp changeShort interest spike: short interest spike, 6.0M vs usual 2.9M (2025-02-14); 2.1x the same period a year earlier
24 Feb 20258-K and other filingsDirector or officer change
24 Feb 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
20 Feb 20258-K and other filingsA major agreement ended
18 Feb 2025Sharp changeShort interest spike: short interest spike, 5.3M vs usual 2.8M (2025-01-31); 2.4x the same period a year earlier
5 Feb 2025Lobbying filingnew lobbying registration (ALSTON & BIRD LLP)
28 Jan 2025Sharp changeShort interest spike: short interest spike, 4.8M vs usual 2.7M (2025-01-15); 2.1x the same period a year earlier
14 Jan 2025Sharp changeShort interest spike: short interest spike, 4.4M vs usual 2.7M (2024-12-31); 2.0x the same period a year earlier
31 Dec 2024Sharp changeShort interest spike: short interest spike, 4.8M vs usual 2.7M (2024-12-13); 2.2x the same period a year earlier
1 Oct 2024Sharp changeShort interest spike: short interest spike, 3.8M vs usual 2.5M (2024-09-13); 1.5x the same period a year earlier
2 Jul 2024Sharp changeShort interest spike: short interest spike, 3.5M vs usual 2.4M (2024-06-14); 1.1x the same period a year earlier
30 Apr 20248-K and other filingsDirector or officer change
26 Feb 20248-K and other filingsDirector or officer change
30 Jan 20248-K and other filingsDirector or officer change
30 Jan 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
27 Jun 2023Sharp changeWikipedia attention spike: wikipedia attention spike, 5,279 vs usual 2,853.50 (2023-06-19..2023-06-25); 2.4x the same week a year earlier
21 Apr 20238-K and other filingsDirector or officer change
6 Apr 20238-K and other filingsDirector or officer change
6 Apr 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
21 Feb 2023Sharp changeWikipedia attention spike: wikipedia attention spike, 5,040 vs usual 2,503 (2023-02-13..2023-02-19); 2.0x the same week a year earlier
14 Feb 2023Sharp changeMany funds opening a new position: many funds opening a new position, 130 vs usual 80 (2022-12-31); 1.7x the same period a year earlier
26 Oct 20228-K and other filingsDirector or officer change
17 Aug 20228-K and other filingsDirector or officer change
17 Aug 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
14 Jun 2022Sharp changeShort interest spike: short interest spike, 5.3M vs usual 3.2M (2022-05-31); 1.7x the same period a year earlier
5 May 2022Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 19.4M)
26 Apr 20228-K and other filingsDirector or officer change
11 Apr 20228-K and other filingsDirector or officer change
22 Feb 2022Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 1.2B vs usual 795.0M (2021-12-31); 1.6x the same period a year earlier
27 Jan 20228-K and other filingsDirector or officer change
27 Jan 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
19 Jan 2022Lobbying filinglobbying engagement terminated (BROWNSTEIN HYATT FARBER SCHRECK, LLP)
19 Jan 2022Lobbying filinglobbying engagement terminated (TGB STRATEGIES LLC)
Insider net buying (open market)
Month from 1 Jan 2022: -$5.8M published
Month from 1 Feb 2022: -$7.4M published
Month from 1 Mar 2022: -$3.1M published
Month from 1 May 2022: $18.7M published
Month from 1 Jul 2022: $65K published
Month from 1 Oct 2022: -$2.3M published
Month from 1 Nov 2022: -$7.3M published
Month from 1 Feb 2023: -$20.7M published
Month from 1 Apr 2023: -$3.5M published
Month from 1 May 2023: -$4.6M published
Month from 1 Aug 2023: -$2.6M published
Month from 1 Feb 2024: -$7.3M published
Month from 1 Mar 2024: -$400K published
Month from 1 May 2024: -$5.2M published
Month from 1 Jul 2024: -$2.1M published
Month from 1 Aug 2024: -$2.9M published
Month from 1 Sep 2024: -$3.2M published
Month from 1 Nov 2024: -$2.9M published
Month from 1 Feb 2025: -$3.1M published
Month from 1 Mar 2025: $8K published
Month from 1 May 2025: -$5.8M published
Month from 1 Sep 2025: -$1.6M published
Month from 1 Nov 2025: -$1.8M published
Month from 1 Feb 2026: -$29.3M published
Month from 1 Nov 2026: -$18.3M published
H-1B/E-3 applications certified
Quarter from 1 Jul 2022: 2 published
Quarter from 1 Apr 2025: 1 published
Quarter from 1 Jul 2025: 1 published
Quarter from 1 Oct 2026: 60 published
Revenue per quarter
Quarter ended 31 Dec 2021: $15.1B, +5.4% on a year earlier; public on 19 Feb 2022
Quarter ended 31 Mar 2022: $14.9B, +6.9% on a year earlier; public on 4 May 2022
Quarter ended 30 Jun 2022: $14.8B, +2.7% on a year earlier; public on 2 Aug 2022
Quarter ended 30 Sep 2022: $15.0B, -2.0% on a year earlier; public on 2 Nov 2022
Quarter ended 31 Dec 2022: $15.5B, +2.9% on a year earlier; public on 18 Feb 2023
Quarter ended 31 Mar 2023: $15.6B, +4.3% on a year earlier; public on 28 Apr 2023
Quarter ended 30 Jun 2023: $15.9B, +7.0% on a year earlier; public on 3 Aug 2023
Quarter ended 30 Sep 2023: $16.2B, +8.3% on a year earlier; public on 27 Oct 2023
Quarter ended 31 Dec 2023: $17.3B, +12% on a year earlier; public on 17 Feb 2024
Quarter ended 31 Mar 2024: $17.3B, +11% on a year earlier; public on 3 May 2024
Quarter ended 30 Jun 2024: $17.5B, +10% on a year earlier; public on 30 Jul 2024
Quarter ended 30 Sep 2024: $17.5B, +7.9% on a year earlier; public on 1 Nov 2024
Quarter ended 31 Dec 2024: $18.3B, +5.7% on a year earlier; public on 15 Feb 2025
Quarter ended 31 Mar 2025: $18.3B, +5.7% on a year earlier; public on 2 May 2025
Quarter ended 30 Jun 2025: $18.6B, +6.4% on a year earlier; public on 5 Aug 2025
Quarter ended 30 Sep 2025: $19.2B, +9.6% on a year earlier; public on 31 Oct 2025
Quarter ended 31 Dec 2025: $19.5B, +6.7% on a year earlier; public on 11 Feb 2026
Quarter ended 31 Mar 2026: $19.1B, +4.3% on a year earlier; public on 30 Apr 2026
Quarter ended 30 Jun 2026: $20.2B, +8.7% on a year earlier; public on 29 Jul 2026
Quarter ended 30 Sep 2026: $19.8B, +3.6% on a year earlier; public on 30 Oct 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $1.2B, +59% on a year earlier; public on 19 Feb 2022
Quarter ended 31 Mar 2022: $861.0M, +32% on a year earlier; public on 4 May 2022
Quarter ended 30 Jun 2022: $1.1B, +28% on a year earlier; public on 2 Aug 2022
Quarter ended 30 Sep 2022: $1.1B, +27% on a year earlier; public on 2 Nov 2022
Quarter ended 31 Dec 2022: $1.3B, +11% on a year earlier; public on 18 Feb 2023
Quarter ended 31 Mar 2023: $1.2B, +39% on a year earlier; public on 28 Apr 2023
Quarter ended 30 Jun 2023: $1.2B, +15% on a year earlier; public on 3 Aug 2023
Quarter ended 30 Sep 2023: $1.1B, +1.4% on a year earlier; public on 27 Oct 2023
Quarter ended 31 Dec 2023: $1.2B, -12% on a year earlier; public on 17 Feb 2024
Quarter ended 31 Mar 2024: $1.1B, -6.6% on a year earlier; public on 3 May 2024
Quarter ended 30 Jun 2024: $1.3B, +3.2% on a year earlier; public on 30 Jul 2024
Quarter ended 30 Sep 2024: $1.2B, +3.8% on a year earlier; public on 1 Nov 2024
Quarter ended 31 Dec 2024: $1.3B, +11% on a year earlier; public on 15 Feb 2025
Quarter ended 31 Mar 2025: $991.0M, -11% on a year earlier; public on 2 May 2025
Quarter ended 30 Jun 2025: $1.2B, -8.2% on a year earlier; public on 5 Aug 2025
Quarter ended 30 Sep 2025: $1.3B, +8.1% on a year earlier; public on 31 Oct 2025
Quarter ended 31 Dec 2025: $1.5B, +16% on a year earlier; public on 11 Feb 2026
Quarter ended 31 Mar 2026: $1.1B, +13% on a year earlier; public on 30 Apr 2026
Quarter ended 30 Jun 2026: $1.2B, +4.7% on a year earlier; public on 29 Jul 2026
Quarter ended 30 Sep 2026: $1.4B, +5.4% on a year earlier; public on 30 Oct 2026
Institutional holders (13F filers)
31 Dec 2021 report: 838; public on 14 Feb 2022
31 Mar 2022 report: 910; public on 16 May 2022
30 Jun 2022 report: 822; public on 15 Aug 2022
30 Sep 2022 report: 790; public on 14 Nov 2022
31 Dec 2022 report: 884; public on 14 Feb 2023
31 Mar 2023 report: 898; public on 15 May 2023
30 Jun 2023 report: 941; public on 14 Aug 2023
30 Sep 2023 report: 933; public on 14 Nov 2023
31 Dec 2023 report: 982; public on 14 Feb 2024
31 Mar 2024 report: 1,065; public on 15 May 2024
30 Jun 2024 report: 1,104; public on 14 Aug 2024
30 Sep 2024 report: 1,136; public on 14 Nov 2024
31 Dec 2024 report: 1,124; public on 14 Feb 2025
31 Mar 2025 report: 1,164; public on 15 May 2025
30 Jun 2025 report: 1,197; public on 14 Aug 2025
30 Sep 2025 report: 1,228; public on 14 Nov 2025
31 Dec 2025 report: 1,333; public on 17 Feb 2026
31 Mar 2026 report: 1,380; public on 15 May 2026
30 Jun 2026 report: 1,310; public on 14 Aug 2026
30 Sep 2026 report: 1,337; public on 16 Nov 2026
Federal obligations
Month from 1 Feb 2022: -$7K published
Month from 1 Mar 2022: $42K published
Month from 1 Jul 2022: $0 published
Month from 1 Oct 2022: $80K published
Month from 1 Dec 2022: $0 published
Month from 1 Jan 2023: $0 published
Month from 1 Jun 2023: $11K published
Month from 1 Oct 2023: $90K published
Month from 1 Nov 2023: $1K published
Month from 1 Jan 2024: $23K published
Month from 1 Feb 2024: -$9K published
Lobbying spend
Quarter from 1 Jan 2022: $660K published
Quarter from 1 Apr 2022: $1.5M published
Quarter from 1 Jul 2022: $730K published
Quarter from 1 Oct 2022: $860K published
Quarter from 1 Jan 2023: $780K published
Quarter from 1 Apr 2023: $800K published
Quarter from 1 Jul 2023: $1.2M published
Quarter from 1 Oct 2023: $1.2M published
Quarter from 1 Jan 2024: $1.2M published
Quarter from 1 Apr 2024: $1.0M published
Quarter from 1 Jul 2024: $1.0M published
Quarter from 1 Oct 2024: $510K published
Quarter from 1 Jan 2025: $780K published
Quarter from 1 Apr 2025: $540K published
Quarter from 1 Jul 2025: $1.8M published
Quarter from 1 Oct 2025: $550K published
Quarter from 1 Jan 2026: $1.5M published
Quarter from 1 Apr 2026: $1.8M published
Quarter from 1 Jul 2026: $610K published
Quarter from 1 Oct 2026: $1.8M published

What is unusual now

  • Made public in the last 90 days: it reported $1.7M of lobbying spend for the quarter ended 30 Sep 2026, 3.1× the same quarter last year; it also had 6.1M shares sold short in the 14 Aug 2026 report, 1.5× the same report last year.
  • Lobbying spend jump: reported $1.7M of lobbying spend for the quarter ended 30 Sep 2026, 3.1× the same quarter last year Public on 20 Oct 2026.
  • Short interest spike: had 6.1M shares sold short in the 14 Aug 2026 report, 1.5× the same report last year Public on 26 Aug 2026.
  • Insider net buying (open market): Insiders sold a net $47.5M in the last 12 months (the 12 months before: -$12.3M).

Latest records

The names and amounts behind the totals, newest first

Last 90 days: 3 sales, $18.3M; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
10 Nov 2026Erica RossittoSVP & Chief Nurse ExecutiveSellafter exercising options3,500$505.81$1.8MForm 4
6 Nov 2026Michael J SchlosserEVP and Chief Clinical OfficerSell1,200$494.65$594KForm 4
6 Nov 2026Jon M FosterEVP and COOSellafter exercising options31,713$500.98$15.9MForm 4
18 Feb 2026Michael R McAleveyEVP & Chief Legal & Admin Off.Sellafter exercising options1,694$533.37$904KForm 4
12 Feb 2026Christopher F. WyattSVP & ControllerSell4,000$505.00$2.0MForm 4
12 Feb 2026Jennifer BerresSVP & Chief Human Res. OfficerSell8,020$514.58$4.1MForm 4
5 Feb 2026Samuel N HazenCEOSell42,877$501.04$21.5MForm 4
5 Feb 2026Michael S. CuffeEVP and Chief Clinical OfficerSell1,500$498.09$747KForm 4

1,337 institutions reported shares at the end of Q3 2026, 58% of the shares outstanding; 135 opened a position, 118 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.12.4M5.95%$5.3B-574K-4.4%
Vanguard Capital Management LLC9.4M4.51%$4.0B-720K-7.1%
Sanders Capital, LLC8.8M4.21%$3.8B-37K-0.4%
State Street Corp7.0M3.35%$3.0B-478K-6.4%
Wellington Management Group LLP4.3M2.06%$1.8B-405K-8.6%
Geode Capital Management, LLC3.5M1.68%$1.5B-162K-4.4%
First Eagle Investment Management, LLC3.3M1.56%$1.4B-3.3M-50%
Morgan Stanley2.6M1.26%$1.1B+49K+1.9%
Vanguard Portfolio Management LLC2.6M1.22%$1.1B-157K-5.8%
Capital World Investors2.6M1.22%$1.1B+576K+29%

Federal contracts

All 1 federal contracts

No new award in 12 months; the latest was signed 2 Oct 2019. New awards only; later changes to an award are not listed.

SignedAgencyAmountWhat forSource
2 Oct 2019Department of Veterans Affairs$2.9MOFF-SITE IN-PATIENT EMERGENCY CARDIOLOGY - FUNDING ACTION TO FUND OPTION YEAR THREE (3).USAspending

Company events

All 68 company events

In 12 months: 2 director or officer changes, 2 major agreements. Results releases and routine reports are left out.

FiledWhat happenedSource
5 Nov 2026Signed a major agreementSame filing: took on new debt8-K
18 Jun 2026Director or officer change8-K
30 Apr 2026Signed a major agreementSame filing: took on new debt8-K
25 Feb 2026Director or officer change8-K
31 Oct 2025Signed a major agreementSame filing: took on new debt8-K
11 Jul 2025Director or officer change8-K
29 Apr 2025Director or officer changeSame filing: changed its bylaws or fiscal year, shareholder vote results8-K
24 Feb 2025Director or officer change8-K

Reported lobbying spend: $1.8M in Q3 2026, $610K in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
26 Aug 2026NewJeffrey J. Kimbell & Associates, Inc.for Hca Management Services, L.P.Issues related to the use of artificial intelligence in health care; Issues related to Interoperability; Issues related to Health Data Privacy; Issues related to Health Information TechnologyHealth issuesFiling
31 May 2025EndedHorizon Government Affairsfor Hca Management Services, L.P.Not statedFiling
1 Feb 2025NewRubin, Turnbull & Associatesfor Hca Healthcare, Inc.Advocate on issues related to healthcare, hospitals, and regulatory framework.Health issuesFiling
1 Jan 2025NewAlston & Bird LLPfor Hca HealthcareReimbursement issues for hospitals.Health issues, Medicare/Medicaid, TaxationFiling
31 Dec 2021EndedBrownstein Hyatt Farber Schreck, LLPfor Hca-Healthone LLC Dba Rose Medical CenterIssues related to development of medical facility in DenverHealth issuesFiling
31 Dec 2021EndedTGB Strategies LLCfor Brownstein Hyatt Farber Schreck Obo Hca-Healthone LLC Dba Rose Medical CenterIssues related to development of medical facility in DenverHealth issuesFiling
21 Jun 2021NewTGB Strategies LLCfor Brownstein Hyatt Farber Schreck Obo Hca-Healthone LLC Dba Rose Medical CenterIssues related to development of medical facility in DenverHealth issuesFiling
21 Jun 2021NewBrownstein Hyatt Farber Schreck, LLPfor Hca-Healthone LLC Dba Rose Medical CenterIssues related to development of medical facilityHealth issuesFiling

The 5 newest of 465 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

21 Feb 2023confirmed

Confirmed across sources Attention and Institutional holdings

HCA Healthcare (HCA): saw 130 13F filers open a new position in the quarter ended 31 Dec 2022, 1.7× the same quarter last year, while it drew 5,040 Wikipedia page views in the week of 13 Feb 2023, 2.0× the same week last year. Two unrelated kinds of activity within 7 days.

  • Institutional holdings: Many funds opening a new position, became public on 14 Feb 2023
  • Attention: Wikipedia attention spike, became public on 21 Feb 2023
2020-12-31: 812021-03-31: 792021-06-30: 912021-09-30: 1062021-12-31: 782022-03-31: 902022-06-30: 682022-09-30: 722022-12-31: 130
The quarter ended 31 Dec 2022 against the 8 quarters before it. this quarterearliernormal: 80
See the evidence (2 changes)

Institutional holdings: Many funds opening a new position became public on 14 Feb 2023

HCA Healthcare saw 130 13F filers open a new position in the quarter ended 31 Dec 2022, 1.7× the same quarter last year.

This period
130 (the quarter ended 31 Dec 2022)
Normal quarter (median of 8 earlier)
80
Typical spread (median absolute deviation)
9
How far from its usual level
+3.7
Same quarter last year
78
History used
3,379 days
2020-12-31: 812021-03-31: 792021-06-30: 912021-09-30: 1062021-12-31: 782022-03-31: 902022-06-30: 682022-09-30: 722022-12-31: 130
the quarter ended 31 Dec 20228 earlier quartersnormal: 80

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Attention: Wikipedia attention spike became public on 21 Feb 2023

HCA Healthcare drew 5,040 Wikipedia page views in the week of 13 Feb 2023, 2.0× the same week last year.

This period
5,040 (the week of 13 Feb 2023)
Normal week (median of 26 earlier)
2,503
Typical spread (median absolute deviation)
122
How far from its usual level
+10.1
Same week last year
2,526
History used
1,510 days
2022-08-15: 2,5832022-08-22: 2,5022022-08-29: 2,5312022-09-05: 2,5042022-09-12: 2,5102022-09-19: 2,4742022-09-26: 2,3902022-10-03: 2,3732022-10-10: 2,4442022-10-17: 2,6032022-10-24: 2,5162022-10-31: 2,3252022-11-07: 2,5952022-11-14: 3,0672022-11-21: 2,2552022-11-28: 2,4012022-12-05: 2,2532022-12-12: 2,2412022-12-19: 2,1102022-12-26: 1,6382023-01-02: 2,2712023-01-09: 4,5402023-01-16: 2,6112023-01-23: 3,0312023-01-30: 2,7172023-02-06: 2,7552023-02-13: 5,040
the week of 13 Feb 202326 earlier weeksnormal: 2,503

Fires when the period is at least 5.0 robust standard deviations above the company's own median, with 20+ earlier periods, 365+ days of history and a value of at least 5,000.

Check it at the source: Wikimedia page view statistics.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

19 May 2020confirmed

Confirmed across sources Institutional holdings and Lobbying

HCA Healthcare (HCA): reported $880K of lobbying spend for the quarter ended 31 Mar 2020, 2.9× the same quarter last year, while it saw 105 13F filers open a new position in the quarter ended 31 Mar 2020, 1.8× the same quarter last year. Two unrelated kinds of activity within 28 days.

  • Lobbying: Lobbying spend jump, became public on 13 Apr 2020
  • Institutional holdings: Many funds opening a new position, became public on 15 May 2020
2018-03-31: $187K2018-06-30: $160K2018-09-30: $170K2018-12-31: $160K2019-03-31: $304K2019-06-30: $160K2019-09-30: $610K2019-12-31: $979K2020-03-31: $880K
The quarter ended 31 Mar 2020 against the 8 quarters before it. this quarterearliernormal: $178K
See the evidence (2 changes)

Lobbying: Lobbying spend jump became public on 13 Apr 2020

HCA Healthcare reported $880K of lobbying spend for the quarter ended 31 Mar 2020, 2.9× the same quarter last year.

This period
$880K (the quarter ended 31 Mar 2020)
Normal quarter (median of 8 earlier)
$178K
Typical spread (median absolute deviation)
$18K
How far from its usual level
+25.6
Same quarter last year
$304K
History used
3,288 days
2018-03-31: $187K2018-06-30: $160K2018-09-30: $170K2018-12-31: $160K2019-03-31: $304K2019-06-30: $160K2019-09-30: $610K2019-12-31: $979K2020-03-31: $880K
the quarter ended 31 Mar 20208 earlier quartersnormal: $178K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.

Check it at the source: Senate/House lobbying disclosures (LDA).

Institutional holdings: Many funds opening a new position became public on 15 May 2020

HCA Healthcare saw 105 13F filers open a new position in the quarter ended 31 Mar 2020, 1.8× the same quarter last year.

This period
105 (the quarter ended 31 Mar 2020)
Normal quarter (median of 8 earlier)
64
Typical spread (median absolute deviation)
3.5
How far from its usual level
+6.4
Same quarter last year
59
History used
2,374 days
2018-03-31: 932018-06-30: 702018-09-30: 642018-12-31: 642019-03-31: 592019-06-30: 492019-09-30: 622019-12-31: 662020-03-31: 105
the quarter ended 31 Mar 20208 earlier quartersnormal: 64

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

22 Oct 2019confirmed

Confirmed across sources Government contracts and Lobbying

HCA Healthcare (HCA): won its first federal award in our data, a $2.9M Department of Veterans Affairs contract, while it reported $610K of lobbying spend for the quarter ended 30 Sep 2019, 3.6× the same quarter last year. Two unrelated kinds of activity within 14 days.

  • Government contracts: First federal award, became public on 8 Oct 2019
  • Lobbying: Lobbying spend jump, became public on 17 Oct 2019
2017-09-30: $160K2017-12-31: $288K2018-03-31: $187K2018-06-30: $160K2018-09-30: $170K2018-12-31: $160K2019-03-31: $304K2019-06-30: $160K2019-09-30: $610K
The quarter ended 30 Sep 2019 against the 8 quarters before it. this quarterearliernormal: $165K
See the evidence (2 changes)

Government contracts: First federal award became public on 8 Oct 2019

HCA Healthcare won its first federal award in our data, a $2.9M Department of Veterans Affairs contract.

Source coverage starts
7 Oct 2007
Earlier events of other kinds
0

"First" means first in our data: it fires only when the source's history began at least 365 days earlier.

Lobbying: Lobbying spend jump became public on 17 Oct 2019

HCA Healthcare reported $610K of lobbying spend for the quarter ended 30 Sep 2019, 3.6× the same quarter last year.

This period
$610K (the quarter ended 30 Sep 2019)
Normal quarter (median of 8 earlier)
$165K
Typical spread (median absolute deviation)
$5K
How far from its usual level
+22.2
Same quarter last year
$170K
History used
3,014 days
2017-09-30: $160K2017-12-31: $288K2018-03-31: $187K2018-06-30: $160K2018-09-30: $170K2018-12-31: $160K2019-03-31: $304K2019-06-30: $160K2019-09-30: $610K
the quarter ended 30 Sep 20198 earlier quartersnormal: $165K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.

Check it at the source: Senate/House lobbying disclosures (LDA).

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 20 Oct 2026Lobbying change

    reported $1.7M of lobbying spend for the quarter ended 30 Sep 2026, 3.1× the same quarter last year.

    Same quarter last year: $550K; its normal quarter is $695K.

    See the evidence
    This period
    $1.7M (the quarter ended 30 Sep 2026)
    Normal quarter (median of 8 earlier)
    $695K
    Typical spread (median absolute deviation)
    $170K
    How far from its usual level
    +4.1
    Same quarter last year
    $550K
    History used
    6,757 days
    2024-09-30: $510K2024-12-31: $780K2025-03-31: $540K2025-06-30: $1.8M2025-09-30: $550K2025-12-31: $1.5M2026-03-31: $1.8M2026-06-30: $610K2026-09-30: $1.7M
    the quarter ended 30 Sep 20268 earlier quartersnormal: $695K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.

    Check it at the source: Senate/House lobbying disclosures (LDA).

  2. 11 Oct 2026Lobbying record

    HCA MANAGEMENT SERVICES, L.P.: new lobbying registration (JEFFREY J. KIMBELL & ASSOCIATES, INC.) (dated 26 Aug 2026)

  3. 26 Aug 2026Short interest and volume change

    had 6.1M shares sold short in the 14 Aug 2026 report, 1.5× the same report last year.

    Same report last year: 4.1M; its normal report is 4.2M.

    See the evidence
    This period
    6.1M (the 14 Aug 2026 report)
    Normal report (median of 24 earlier)
    4.2M
    Typical spread (median absolute deviation)
    334K
    How far from its usual level
    +3.9
    Same report last year
    4.1M
    History used
    3,150 days
    2025-08-15: 4.1M2025-08-29: 4.3M2025-09-15: 4.2M2025-09-30: 3.6M2025-10-15: 3.3M2025-10-31: 4.0M2025-11-14: 4.5M2025-11-28: 4.9M2025-12-15: 4.5M2025-12-31: 4.1M2026-01-15: 3.9M2026-01-30: 4.1M2026-02-13: 3.9M2026-02-27: 3.5M2026-03-13: 3.3M2026-03-31: 3.6M2026-04-15: 4.0M2026-04-30: 4.3M2026-05-15: 4.5M2026-05-29: 5.2M2026-06-15: 5.2M2026-06-30: 5.4M2026-07-15: 5.8M2026-07-31: 6.1M2026-08-14: 6.1M
    the 14 Aug 2026 report24 earlier reportsnormal: 4.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  4. 12 Aug 2026Short interest and volume change

    had 6.1M shares sold short in the 31 Jul 2026 report, 1.5× the same report last year.

    Same report last year: 4.1M; its normal report is 4.1M.

    See the evidence
    This period
    6.1M (the 31 Jul 2026 report)
    Normal report (median of 24 earlier)
    4.1M
    Typical spread (median absolute deviation)
    344K
    How far from its usual level
    +3.8
    Same report last year
    4.1M
    History used
    3,136 days
    2025-07-31: 4.1M2025-08-15: 4.1M2025-08-29: 4.3M2025-09-15: 4.2M2025-09-30: 3.6M2025-10-15: 3.3M2025-10-31: 4.0M2025-11-14: 4.5M2025-11-28: 4.9M2025-12-15: 4.5M2025-12-31: 4.1M2026-01-15: 3.9M2026-01-30: 4.1M2026-02-13: 3.9M2026-02-27: 3.5M2026-03-13: 3.3M2026-03-31: 3.6M2026-04-15: 4.0M2026-04-30: 4.3M2026-05-15: 4.5M2026-05-29: 5.2M2026-06-15: 5.2M2026-06-30: 5.4M2026-07-15: 5.8M2026-07-31: 6.1M
    the 31 Jul 2026 report24 earlier reportsnormal: 4.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  5. 18 Jun 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  6. 18 Jun 2026Filings record

    Director or officer change

  7. 19 May 2026Attention change

    drew 6,340 Wikipedia page views in the week of 11 May 2026, 2.0× the same week last year.

    Same week last year: 3,198; its normal week is 2,834.

    See the evidence
    This period
    6,340 (the week of 11 May 2026)
    Normal week (median of 26 earlier)
    2,834
    Typical spread (median absolute deviation)
    176
    How far from its usual level
    +12.4
    Same week last year
    3,198
    History used
    2,693 days
    2025-11-10: 2,8592025-11-17: 2,9482025-11-24: 2,4952025-12-01: 2,8802025-12-08: 2,8302025-12-15: 2,4992025-12-22: 2,0492025-12-29: 2,3842026-01-05: 3,2372026-01-12: 3,1572026-01-19: 3,1962026-01-26: 3,0012026-02-02: 2,7112026-02-09: 2,6272026-02-16: 2,9972026-02-23: 2,7952026-03-02: 2,4312026-03-09: 2,4512026-03-16: 2,7372026-03-23: 2,6502026-03-30: 2,9052026-04-06: 2,9122026-04-13: 3,2762026-04-20: 3,1952026-04-27: 2,8332026-05-04: 2,8362026-05-11: 6,340
    the week of 11 May 202626 earlier weeksnormal: 2,834

    Fires when the period is at least 5.0 robust standard deviations above the company's own median, with 20+ earlier periods, 365+ days of history and a value of at least 5,000.

    Check it at the source: Wikimedia page view statistics.

  8. 13 May 2026Institutional holdings record

    Capital International Investors opened a $1.4B position (2026Q1 13F)

  9. 25 Feb 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  10. 25 Feb 2026Filings record

    Director or officer change

  11. 11 Jul 2025Filings record

    Director or officer change

  12. 7 Jul 2025Lobbying record

    HCA MANAGEMENT SERVICES, L.P.: lobbying engagement terminated (HORIZON GOVERNMENT AFFAIRS) (dated 31 May 2025)

  13. 29 Apr 2025Filings record

    Director or officer change

  14. 10 Apr 2025Short interest and volume change

    had 5.6M shares sold short in the 31 Mar 2025 report, 2.1× the same report last year.

    Same report last year: 2.6M; its normal report is 3.0M.

    See the evidence
    This period
    5.6M (the 31 Mar 2025 report)
    Normal report (median of 24 earlier)
    3.0M
    Typical spread (median absolute deviation)
    485K
    How far from its usual level
    +3.6
    Same report last year
    2.6M
    History used
    2,649 days
    2024-03-28: 2.6M2024-04-15: 2.6M2024-04-30: 2.5M2024-05-15: 2.7M2024-05-31: 3.0M2024-06-14: 3.5M2024-06-28: 2.5M2024-07-15: 2.4M2024-07-31: 2.6M2024-08-15: 2.7M2024-08-30: 3.0M2024-09-13: 3.8M2024-09-30: 2.7M2024-10-15: 2.9M2024-10-31: 2.6M2024-11-15: 3.0M2024-11-29: 3.5M2024-12-13: 4.8M2024-12-31: 4.4M2025-01-15: 4.8M2025-01-31: 5.3M2025-02-14: 6.0M2025-02-28: 5.9M2025-03-14: 4.9M2025-03-31: 5.6M
    the 31 Mar 2025 report24 earlier reportsnormal: 3.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  15. 29 Mar 2025Insiders record

    BANK OF AMERICA CORP /DE/ (ten percent owner) and 2 other(s) bought 3,436 shares of HCA ($88,208) (dated 28 Mar 2025)

  16. 12 Mar 2025Short interest and volume change

    had 5.9M shares sold short in the 28 Feb 2025 report, 2.2× the same report last year.

    Same report last year: 2.7M; its normal report is 2.9M.

    See the evidence
    This period
    5.9M (the 28 Feb 2025 report)
    Normal report (median of 24 earlier)
    2.9M
    Typical spread (median absolute deviation)
    340K
    How far from its usual level
    +5.9
    Same report last year
    2.7M
    History used
    2,618 days
    2024-02-29: 2.7M2024-03-15: 3.0M2024-03-28: 2.6M2024-04-15: 2.6M2024-04-30: 2.5M2024-05-15: 2.7M2024-05-31: 3.0M2024-06-14: 3.5M2024-06-28: 2.5M2024-07-15: 2.4M2024-07-31: 2.6M2024-08-15: 2.7M2024-08-30: 3.0M2024-09-13: 3.8M2024-09-30: 2.7M2024-10-15: 2.9M2024-10-31: 2.6M2024-11-15: 3.0M2024-11-29: 3.5M2024-12-13: 4.8M2024-12-31: 4.4M2025-01-15: 4.8M2025-01-31: 5.3M2025-02-14: 6.0M2025-02-28: 5.9M
    the 28 Feb 2025 report24 earlier reportsnormal: 2.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  17. 11 Mar 2025Lobbying record

    HCA HEALTHCARE, INC.: new lobbying registration (RUBIN, TURNBULL & ASSOCIATES) (dated 1 Feb 2025)

  18. 27 Feb 2025Short interest and volume change

    had 6.0M shares sold short in the 14 Feb 2025 report, 2.1× the same report last year.

    Same report last year: 2.9M; its normal report is 2.9M.

    See the evidence
    This period
    6.0M (the 14 Feb 2025 report)
    Normal report (median of 24 earlier)
    2.9M
    Typical spread (median absolute deviation)
    260K
    How far from its usual level
    +8.2
    Same report last year
    2.9M
    History used
    2,604 days
    2024-02-15: 2.9M2024-02-29: 2.7M2024-03-15: 3.0M2024-03-28: 2.6M2024-04-15: 2.6M2024-04-30: 2.5M2024-05-15: 2.7M2024-05-31: 3.0M2024-06-14: 3.5M2024-06-28: 2.5M2024-07-15: 2.4M2024-07-31: 2.6M2024-08-15: 2.7M2024-08-30: 3.0M2024-09-13: 3.8M2024-09-30: 2.7M2024-10-15: 2.9M2024-10-31: 2.6M2024-11-15: 3.0M2024-11-29: 3.5M2024-12-13: 4.8M2024-12-31: 4.4M2025-01-15: 4.8M2025-01-31: 5.3M2025-02-14: 6.0M
    the 14 Feb 2025 report24 earlier reportsnormal: 2.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  19. 24 Feb 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  20. 24 Feb 2025Filings record

    Director or officer change

  21. 20 Feb 2025Filings record

    A major agreement ended

  22. 12 Feb 2025Short interest and volume change

    had 5.3M shares sold short in the 31 Jan 2025 report, 2.4× the same report last year.

    Same report last year: 2.2M; its normal report is 2.8M.

    See the evidence
    This period
    5.3M (the 31 Jan 2025 report)
    Normal report (median of 24 earlier)
    2.8M
    Typical spread (median absolute deviation)
    230K
    How far from its usual level
    +7.5
    Same report last year
    2.2M
    History used
    2,590 days
    2024-01-31: 2.2M2024-02-15: 2.9M2024-02-29: 2.7M2024-03-15: 3.0M2024-03-28: 2.6M2024-04-15: 2.6M2024-04-30: 2.5M2024-05-15: 2.7M2024-05-31: 3.0M2024-06-14: 3.5M2024-06-28: 2.5M2024-07-15: 2.4M2024-07-31: 2.6M2024-08-15: 2.7M2024-08-30: 3.0M2024-09-13: 3.8M2024-09-30: 2.7M2024-10-15: 2.9M2024-10-31: 2.6M2024-11-15: 3.0M2024-11-29: 3.5M2024-12-13: 4.8M2024-12-31: 4.4M2025-01-15: 4.8M2025-01-31: 5.3M
    the 31 Jan 2025 report24 earlier reportsnormal: 2.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  23. 5 Feb 2025Lobbying record

    HCA HEALTHCARE: new lobbying registration (ALSTON & BIRD LLP) (dated 1 Jan 2025)

  24. 28 Jan 2025Short interest and volume change

    had 4.8M shares sold short in the 15 Jan 2025 report, 2.1× the same report last year.

    Same report last year: 2.3M; its normal report is 2.7M.

    See the evidence
    This period
    4.8M (the 15 Jan 2025 report)
    Normal report (median of 24 earlier)
    2.7M
    Typical spread (median absolute deviation)
    248K
    How far from its usual level
    +5.7
    Same report last year
    2.3M
    History used
    2,574 days
    2024-01-12: 2.3M2024-01-31: 2.2M2024-02-15: 2.9M2024-02-29: 2.7M2024-03-15: 3.0M2024-03-28: 2.6M2024-04-15: 2.6M2024-04-30: 2.5M2024-05-15: 2.7M2024-05-31: 3.0M2024-06-14: 3.5M2024-06-28: 2.5M2024-07-15: 2.4M2024-07-31: 2.6M2024-08-15: 2.7M2024-08-30: 3.0M2024-09-13: 3.8M2024-09-30: 2.7M2024-10-15: 2.9M2024-10-31: 2.6M2024-11-15: 3.0M2024-11-29: 3.5M2024-12-13: 4.8M2024-12-31: 4.4M2025-01-15: 4.8M
    the 15 Jan 2025 report24 earlier reportsnormal: 2.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  25. 14 Jan 2025Short interest and volume change

    had 4.4M shares sold short in the 31 Dec 2024 report, 2.0× the same report last year.

    Same report last year: 2.2M; its normal report is 2.7M.

    See the evidence
    This period
    4.4M (the 31 Dec 2024 report)
    Normal report (median of 24 earlier)
    2.7M
    Typical spread (median absolute deviation)
    248K
    How far from its usual level
    +4.7
    Same report last year
    2.2M
    History used
    2,559 days
    2023-12-29: 2.2M2024-01-12: 2.3M2024-01-31: 2.2M2024-02-15: 2.9M2024-02-29: 2.7M2024-03-15: 3.0M2024-03-28: 2.6M2024-04-15: 2.6M2024-04-30: 2.5M2024-05-15: 2.7M2024-05-31: 3.0M2024-06-14: 3.5M2024-06-28: 2.5M2024-07-15: 2.4M2024-07-31: 2.6M2024-08-15: 2.7M2024-08-30: 3.0M2024-09-13: 3.8M2024-09-30: 2.7M2024-10-15: 2.9M2024-10-31: 2.6M2024-11-15: 3.0M2024-11-29: 3.5M2024-12-13: 4.8M2024-12-31: 4.4M
    the 31 Dec 2024 report24 earlier reportsnormal: 2.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  26. 25 Dec 2024Short interest and volume change

    had 4.8M shares sold short in the 13 Dec 2024 report, 2.2× the same report last year.

    Same report last year: 2.1M; its normal report is 2.7M.

    See the evidence
    This period
    4.8M (the 13 Dec 2024 report)
    Normal report (median of 24 earlier)
    2.7M
    Typical spread (median absolute deviation)
    247K
    How far from its usual level
    +5.8
    Same report last year
    2.1M
    History used
    2,541 days
    2023-12-15: 2.1M2023-12-29: 2.2M2024-01-12: 2.3M2024-01-31: 2.2M2024-02-15: 2.9M2024-02-29: 2.7M2024-03-15: 3.0M2024-03-28: 2.6M2024-04-15: 2.6M2024-04-30: 2.5M2024-05-15: 2.7M2024-05-31: 3.0M2024-06-14: 3.5M2024-06-28: 2.5M2024-07-15: 2.4M2024-07-31: 2.6M2024-08-15: 2.7M2024-08-30: 3.0M2024-09-13: 3.8M2024-09-30: 2.7M2024-10-15: 2.9M2024-10-31: 2.6M2024-11-15: 3.0M2024-11-29: 3.5M2024-12-13: 4.8M
    the 13 Dec 2024 report24 earlier reportsnormal: 2.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  27. 25 Sep 2024Short interest and volume change

    had 3.8M shares sold short in the 13 Sep 2024 report, 1.5× the same report last year.

    Same report last year: 2.5M; its normal report is 2.5M.

    See the evidence
    This period
    3.8M (the 13 Sep 2024 report)
    Normal report (median of 24 earlier)
    2.5M
    Typical spread (median absolute deviation)
    167K
    How far from its usual level
    +5.0
    Same report last year
    2.5M
    History used
    2,450 days
    2023-09-15: 2.5M2023-09-29: 2.4M2023-10-13: 2.3M2023-10-31: 2.5M2023-11-15: 2.5M2023-11-30: 2.1M2023-12-15: 2.1M2023-12-29: 2.2M2024-01-12: 2.3M2024-01-31: 2.2M2024-02-15: 2.9M2024-02-29: 2.7M2024-03-15: 3.0M2024-03-28: 2.6M2024-04-15: 2.6M2024-04-30: 2.5M2024-05-15: 2.7M2024-05-31: 3.0M2024-06-14: 3.5M2024-06-28: 2.5M2024-07-15: 2.4M2024-07-31: 2.6M2024-08-15: 2.7M2024-08-30: 3.0M2024-09-13: 3.8M
    the 13 Sep 2024 report24 earlier reportsnormal: 2.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  28. 27 Jun 2024Short interest and volume change

    had 3.5M shares sold short in the 14 Jun 2024 report, 1.1× the same report last year.

    Same report last year: 3.2M; its normal report is 2.4M.

    See the evidence
    This period
    3.5M (the 14 Jun 2024 report)
    Normal report (median of 24 earlier)
    2.4M
    Typical spread (median absolute deviation)
    197K
    How far from its usual level
    +3.7
    Same report last year
    3.2M
    History used
    2,359 days
    2023-06-15: 3.2M2023-06-30: 2.1M2023-07-14: 2.4M2023-07-31: 2.0M2023-08-15: 2.3M2023-08-31: 2.4M2023-09-15: 2.5M2023-09-29: 2.4M2023-10-13: 2.3M2023-10-31: 2.5M2023-11-15: 2.5M2023-11-30: 2.1M2023-12-15: 2.1M2023-12-29: 2.2M2024-01-12: 2.3M2024-01-31: 2.2M2024-02-15: 2.9M2024-02-29: 2.7M2024-03-15: 3.0M2024-03-28: 2.6M2024-04-15: 2.6M2024-04-30: 2.5M2024-05-15: 2.7M2024-05-31: 3.0M2024-06-14: 3.5M
    the 14 Jun 2024 report24 earlier reportsnormal: 2.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  29. 30 Apr 2024Filings record

    Director or officer change

  30. 26 Feb 2024Filings record

    Director or officer change

  31. 30 Jan 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  32. 30 Jan 2024Filings record

    Director or officer change

  33. 27 Jun 2023Attention change

    drew 5,279 Wikipedia page views in the week of 19 Jun 2023, 2.4× the same week last year.

    Same week last year: 2,225; its normal week is 2,854.

    See the evidence
    This period
    5,279 (the week of 19 Jun 2023)
    Normal week (median of 26 earlier)
    2,854
    Typical spread (median absolute deviation)
    191
    How far from its usual level
    +8.5
    Same week last year
    2,225
    History used
    1,636 days
    2022-12-19: 2,1102022-12-26: 1,6382023-01-02: 2,2712023-01-09: 4,5402023-01-16: 2,6112023-01-23: 3,0312023-01-30: 2,7172023-02-06: 2,7552023-02-13: 5,0402023-02-20: 3,3022023-02-27: 2,9682023-03-06: 2,8142023-03-13: 3,9522023-03-20: 3,0582023-03-27: 3,0832023-04-03: 2,8752023-04-10: 2,8012023-04-17: 2,9822023-04-24: 2,9052023-05-01: 2,8322023-05-08: 3,1982023-05-15: 2,8132023-05-22: 2,5442023-05-29: 2,4572023-06-05: 2,7472023-06-12: 2,9742023-06-19: 5,279
    the week of 19 Jun 202326 earlier weeksnormal: 2,854

    Fires when the period is at least 5.0 robust standard deviations above the company's own median, with 20+ earlier periods, 365+ days of history and a value of at least 5,000.

    Check it at the source: Wikimedia page view statistics.

  34. 21 Apr 2023Filings record

    Director or officer change

  35. 6 Apr 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  36. 6 Apr 2023Filings record

    Director or officer change

  37. 21 Feb 2023several at once

    saw 130 13F filers open a new position in the quarter ended 31 Dec 2022, 1.7× the same quarter last year, while it drew 5,040 Wikipedia page views in the week of 13 Feb 2023, 2.0× the same week last year. Two unrelated kinds of activity within 7 days.

    See the evidence (2 changes)

    Institutional holdings: Many funds opening a new position became public on 14 Feb 2023

    HCA Healthcare saw 130 13F filers open a new position in the quarter ended 31 Dec 2022, 1.7× the same quarter last year.

    This period
    130 (the quarter ended 31 Dec 2022)
    Normal quarter (median of 8 earlier)
    80
    Typical spread (median absolute deviation)
    9
    How far from its usual level
    +3.7
    Same quarter last year
    78
    History used
    3,379 days
    2020-12-31: 812021-03-31: 792021-06-30: 912021-09-30: 1062021-12-31: 782022-03-31: 902022-06-30: 682022-09-30: 722022-12-31: 130
    the quarter ended 31 Dec 20228 earlier quartersnormal: 80

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

    Attention: Wikipedia attention spike became public on 21 Feb 2023

    HCA Healthcare drew 5,040 Wikipedia page views in the week of 13 Feb 2023, 2.0× the same week last year.

    This period
    5,040 (the week of 13 Feb 2023)
    Normal week (median of 26 earlier)
    2,503
    Typical spread (median absolute deviation)
    122
    How far from its usual level
    +10.1
    Same week last year
    2,526
    History used
    1,510 days
    2022-08-15: 2,5832022-08-22: 2,5022022-08-29: 2,5312022-09-05: 2,5042022-09-12: 2,5102022-09-19: 2,4742022-09-26: 2,3902022-10-03: 2,3732022-10-10: 2,4442022-10-17: 2,6032022-10-24: 2,5162022-10-31: 2,3252022-11-07: 2,5952022-11-14: 3,0672022-11-21: 2,2552022-11-28: 2,4012022-12-05: 2,2532022-12-12: 2,2412022-12-19: 2,1102022-12-26: 1,6382023-01-02: 2,2712023-01-09: 4,5402023-01-16: 2,6112023-01-23: 3,0312023-01-30: 2,7172023-02-06: 2,7552023-02-13: 5,040
    the week of 13 Feb 202326 earlier weeksnormal: 2,503

    Fires when the period is at least 5.0 robust standard deviations above the company's own median, with 20+ earlier periods, 365+ days of history and a value of at least 5,000.

    Check it at the source: Wikimedia page view statistics.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  38. 21 Feb 2023Attention change

    drew 5,040 Wikipedia page views in the week of 13 Feb 2023, 2.0× the same week last year.

    Same week last year: 2,526; its normal week is 2,503.

    See the evidence
    This period
    5,040 (the week of 13 Feb 2023)
    Normal week (median of 26 earlier)
    2,503
    Typical spread (median absolute deviation)
    122
    How far from its usual level
    +10.1
    Same week last year
    2,526
    History used
    1,510 days
    2022-08-15: 2,5832022-08-22: 2,5022022-08-29: 2,5312022-09-05: 2,5042022-09-12: 2,5102022-09-19: 2,4742022-09-26: 2,3902022-10-03: 2,3732022-10-10: 2,4442022-10-17: 2,6032022-10-24: 2,5162022-10-31: 2,3252022-11-07: 2,5952022-11-14: 3,0672022-11-21: 2,2552022-11-28: 2,4012022-12-05: 2,2532022-12-12: 2,2412022-12-19: 2,1102022-12-26: 1,6382023-01-02: 2,2712023-01-09: 4,5402023-01-16: 2,6112023-01-23: 3,0312023-01-30: 2,7172023-02-06: 2,7552023-02-13: 5,040
    the week of 13 Feb 202326 earlier weeksnormal: 2,503

    Fires when the period is at least 5.0 robust standard deviations above the company's own median, with 20+ earlier periods, 365+ days of history and a value of at least 5,000.

    Check it at the source: Wikimedia page view statistics.

  39. 14 Feb 2023Institutional holdings change

    saw 130 13F filers open a new position in the quarter ended 31 Dec 2022, 1.7× the same quarter last year.

    Same quarter last year: 78; its normal quarter is 80.

    See the evidence
    This period
    130 (the quarter ended 31 Dec 2022)
    Normal quarter (median of 8 earlier)
    80
    Typical spread (median absolute deviation)
    9
    How far from its usual level
    +3.7
    Same quarter last year
    78
    History used
    3,379 days
    2020-12-31: 812021-03-31: 792021-06-30: 912021-09-30: 1062021-12-31: 782022-03-31: 902022-06-30: 682022-09-30: 722022-12-31: 130
    the quarter ended 31 Dec 20228 earlier quartersnormal: 80

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  40. 26 Oct 2022Filings record

    Director or officer change

Showing the newest 40 of 119 entries; narrow the window or the kind of data to see older ones.

Not listed: 464 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0000860730
Ticker
HCA
Domain
hcahealthcare.com
Employer name
Anesthesia Medicine Services of FL, LLC, Christie Clinic PLLC, columbia hca healthcare corporation of central texas, Emergency Medicine Services of FL, LLC and 16 more (20 unverified)
Fein
06-1783116, 30-0705198, 30-0790095, 37-0802668 and 12 more (16 unverified)
Hq location
TN|NASHVILLE|37203 (1 unverified)
Lobbying client
brownstein hyatt farber schreck obo hca healthone llc dba rose medical center, good samaritan hospital, hca, hca healthcare and 3 more
Name
360 Community Alliance, LLC, 5150 Code Grey Holdings, LLC, 52 Alderley Road LLP, Acadiana Care Center, Inc and 2530 more
Uei
VRPYDDSXXHP5
Wikidata
Q1630431
Wikipedia
HCA Healthcare
  • DOL H-1B labor condition applications and PERM certifications142 data points18 Nov 2019 to 28 Sep 2026
  • Federal lobbying disclosures (LDA)30 records, 277 data points30 Jun 1999 to 30 Sep 2026
  • SEC Form 13F institutional holdings3 records, 481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)230 records8 Jan 2016 to 5 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)848 data points31 Dec 2008 to 26 Oct 2026
  • SEC Form 4 insider transactions280 records, 744 data points1 Feb 2016 to 10 Nov 2026
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards1 record, 297 data points15 Jul 2008 to 26 Jan 2024
  • Wikipedia pageviews2882 data points1 Jan 2019 to 21 Nov 2026